Patient
SITE010-0039
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE010 (ESP) (Dr. Silva)
consented 2025-10-12
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-12-10 (study day 232); relationship: not assessed
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-17 (study day 209); relationship: not assessed
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-06-01 (study day 40); relationship: RELATED
Grade 1 Pruritus — outcome: RECOVERED/RESOLVED; onset 2022-05-21 (study day 29); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.